Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Net Assets

v3.24.2.u1
Consolidated Statements of Changes in Net Assets - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at beginning of period (in shares)   84,830,679     84,830,679  
Balance at beginning of period $ 2,515,970 $ 2,477,399 $ 2,172,922 $ 2,108,586 $ 2,477,399 $ 2,108,586
Public offering of common stock, net of offering costs 42,217 5,696 43,204 40,896    
Share‑based compensation 4,883 4,103 4,087 4,100    
Purchase of vested stock for employee payroll tax withholding (7,322) (14) (5,546) (404)    
Dividend reinvestment (in shares)         366,496 374,173
Dividend reinvestment 8,788 8,441 6,880 7,808 $ 17,229 $ 14,688
Amortization of directors’ deferred compensation 106 102 109 121    
Issuance of restricted stock, net of forfeited shares 0   0      
Dividends to stockholders (88,374) (86,904) (73,224) (67,777)    
Net increase in net assets resulting from operations $ 102,688 107,147 106,516 79,592 $ 209,835 186,107
Balance at ending of period (in shares) 86,552,506       86,552,506  
Balance at ending of period $ 2,578,956 $ 2,515,970 $ 2,254,948 $ 2,172,922 $ 2,578,956 $ 2,254,948
Common Stock            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at beginning of period (in shares) 85,163,633 84,833,002 79,794,089 78,506,816 84,833,002 78,506,816
Balance at beginning of period $ 851 $ 848 $ 797 $ 784 $ 848 $ 784
Public offering of common stock, net of offering costs (in shares) 874,309 128,942 1,096,514 1,058,914    
Public offering of common stock, net of offering costs $ 9 $ 1 $ 11 $ 11    
Purchase of vested stock for employee payroll tax withholding (in shares) (154,751) (295) (140,569) (10,489)    
Purchase of vested stock for employee payroll tax withholding $ (2)   $ (1)      
Dividend reinvestment (in shares) 179,511 186,985 174,891 199,282    
Dividend reinvestment $ 2 $ 2 $ 2 $ 2    
Issuance of restricted stock, net of forfeited shares (in shares) 489,804 14,999 506,081 39,566    
Issuance of restricted stock, net of forfeited shares $ 5   $ 5      
Balance at ending of period (in shares) 86,552,506 85,163,633 81,431,006 79,794,089 86,552,506 81,431,006
Balance at ending of period $ 865 $ 851 $ 814 $ 797 $ 865 $ 814
Additional Paid-In Capital            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at beginning of period 2,289,042 2,270,549 2,083,175 2,030,531 2,270,549 2,030,531
Public offering of common stock, net of offering costs 42,208 5,695 43,193 40,885    
Share‑based compensation 4,883 4,103 4,087 4,100    
Purchase of vested stock for employee payroll tax withholding (7,320) (14) (5,545) (404)    
Dividend reinvestment 8,786 8,439 6,878 7,806    
Amortization of directors’ deferred compensation 106 102 109 121    
Issuance of restricted stock, net of forfeited shares (5)   (5)      
Dividends to stockholders 179 168 149 136    
Balance at ending of period 2,337,879 2,289,042 2,132,041 2,083,175 2,337,879 2,132,041
Total Undistributed (Overdistributed) Earnings            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at beginning of period 226,077 206,002 88,950 77,271 206,002 77,271
Dividends to stockholders (88,553) (87,072) (73,373) (67,913)    
Net increase in net assets resulting from operations 102,688 107,147 106,516 79,592    
Balance at ending of period $ 240,212 $ 226,077 $ 122,093 $ 88,950 $ 240,212 $ 122,093